BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7569573)

  • 21. Cystic fibrosis: basic science.
    McAuley DF; Elborn JS
    Paediatr Respir Rev; 2000 Jun; 1(2):93-100. PubMed ID: 12531100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCO3- transport in relation to mucus secretion from submucosal glands.
    Joo NS; Krouse ME; Wu JV; Saenz Y; Jayaraman S; Verkman AS; Wine JJ
    JOP; 2001 Jul; 2(4 Suppl):280-4. PubMed ID: 11875272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From gene to disease; from defective chloride ion transport to cystic fibrosis].
    Scheffer H; van den Ouweland AM; Veeze HJ
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):686-7. PubMed ID: 11530706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cystic fibrosis lung disease and its management].
    Hidaka N; Hidaka Y
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mouse model for the delta F508 allele of cystic fibrosis.
    Zeiher BG; Eichwald E; Zabner J; Smith JJ; Puga AP; McCray PB; Capecchi MR; Welsh MJ; Thomas KR
    J Clin Invest; 1995 Oct; 96(4):2051-64. PubMed ID: 7560099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular repair of a defective CFTR protein in cystic fibrosis.
    Erlinger S
    Clin Res Hepatol Gastroenterol; 2011 Apr; 35(4):254-6. PubMed ID: 21349786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L206W mutation of the cystic fibrosis gene, relatively frequent in French Canadians, is associated with atypical presentations of cystic fibrosis.
    Rozen R; Ferreira-Rajabi L; Robb L; Colman N
    Am J Med Genet; 1995 Jul; 57(3):437-9. PubMed ID: 7545869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CFTR and transepithelial ionic transport abnormalities in cystic fibrosis].
    Becq F
    Arch Pediatr; 2003 Sep; 10 Suppl 2():325s-332s. PubMed ID: 14671929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator.
    Kunzelmann K; Nitschke R
    Exp Nephrol; 2000; 8(6):332-42. PubMed ID: 11014930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CFTR and ENaC functions in cystic fibrosis].
    Palma AG; Kotsias BA; Marino GI
    Medicina (B Aires); 2014; 74(2):133-9. PubMed ID: 24736260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease?
    Pilewski JM; Frizzell RA
    Curr Opin Pulm Med; 1995 Nov; 1(6):435-43. PubMed ID: 9363079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial cell chloride channel activity correlates with improved airway function in cystic fibrosis patients with the major mutant: Delta F508.
    Kidd JF; Bear CE
    Pediatr Res; 2002 Nov; 52(5):625-7. PubMed ID: 12409505
    [No Abstract]   [Full Text] [Related]  

  • 33. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
    Clunes MT; Boucher RC
    Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cystic fibrosis and other channelopathies].
    Edelman A; Saussereau E
    Arch Pediatr; 2012 May; 19 Suppl 1():S13-6. PubMed ID: 22682482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging therapies for cystic fibrosis lung disease.
    Grasemann H; Ratjen F
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):653-9. PubMed ID: 20812885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions.
    Vankeerberghen A; Cuppens H; Cassiman JJ
    J Cyst Fibros; 2002 Mar; 1(1):13-29. PubMed ID: 15463806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ion channels as targets to treat cystic fibrosis lung disease.
    Martin SL; Saint-Criq V; Hwang TC; Csanády L
    J Cyst Fibros; 2018 Mar; 17(2S):S22-S27. PubMed ID: 29102290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biogenesis, traffic, and function of the cystic fibrosis transmembrane conductance regulator.
    Jilling T; Kirk KL
    Int Rev Cytol; 1997; 172():193-241. PubMed ID: 9102394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis.
    Elborn JS
    Lancet; 2016 Nov; 388(10059):2519-2531. PubMed ID: 27140670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations.
    Dean M; Santis G
    Hum Genet; 1994 Apr; 93(4):364-8. PubMed ID: 7513291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.